Osfortis winner of the NutraIngredients Awards 2022

We are proud to announce that our product for bone health, Osfortis^®, is the winner of the 2022 NutraIngredients Awards in the category “Innovations in Women’s Health Award”.

Postmenopausal women are at high risk of developing osteoporosis as the drop in oestrogen levels during menopause is directly linked to reduced bone mass. Therefore, many women seek preventative measures. Osfortis^® contains the patented strain L. reuteri ATCC PTA 6475, in combination with vitamin D, which contributes to the maintenance of normal bones.

Since 2016, the NutraIngredients Awards honour the best and brightest ingredients, finished products, innovations in nutrition and dietary supplements. This year, a new category was released – “Innovations in Women’s Health Award”, which we proudly received.

The motivation from the jury was: “Osfortis^® is a product that helps postmenopausal women stay healthy and active longer, and we are impressed by the strength of the clinical evidence showing the efficacy of L. reuteri in reducing bone loss”.